SCHEMBL23745514

SCHEMBL23745514

Cc1cccc(C(CCNC2CCNCC2)c2cn(CC3CCNCC3)c3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 2/20 0.48
ICMT O60725 1/20 0.34
MPO P05164 3/20 0.33
SLC6A4 P31645 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HTR4 Q13639 3/20 0.32
CNR1 P21554 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CACNA2D1 P54289 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNB1 Q02641 1/20 0.32
CYP19A1 P11511 1/20 0.31
ACHE P22303 1/20 0.31
BACE1 P56817 1/20 0.31
MAPT P10636 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23745636 0.96 SOS1 (0.48) SOS1ICMTMPOCNR1MAPT
Hydrochloric Acid SCHEMBL23722065 0.95 SOS1 (0.47) SOS1ICMTMPOSLC6A4CNR1
SCHEMBL23745598 0.94 SOS1 (0.44) SOS1HTR4CNR1
SCHEMBL23745812 0.94 SOS1 (0.42) SOS1ICMTMPOSLC6A4HDAC1
Hydrochloric Acid SCHEMBL23721995 0.93 SOS1 (0.41) SOS1ICMTMPOSLC6A4HDAC1
Hydrochloric Acid SCHEMBL23722114 0.93 SOS1 (0.44) SOS1HTR4CNR1
SCHEMBL23745733 0.89 CNR1 (0.41) SOS1ICMTMPOCNR1MAPT
Hydrochloric Acid SCHEMBL23722160 0.88 CNR1 (0.40) SOS1ICMTMPOCNR1MAPT
SCHEMBL23722038 0.88 SOS1 (0.41) SOS1ICMTCNR1
SCHEMBL23745874 0.86 ICMT (0.34) SOS1ICMTSLC6A4HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 SOS1 2902/4885ICMT 345/4885MPO 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.